Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$436M |
| 2 |
United Therapeutics
UTHR
|
+$393M |
| 3 |
Amazon
AMZN
|
+$376M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$372M |
| 5 |
Visa
V
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$313M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$272M |
| 3 |
Stellantis
STLA
|
+$222M |
| 4 |
TSMC
TSM
|
+$215M |
| 5 |
Bank of America
BAC
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.76% |
| 2 | Consumer Discretionary | 6.77% |
| 3 | Healthcare | 6.2% |
| 4 | Financials | 5.48% |
| 5 | Communication Services | 4.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DNMR
4626
DELISTED
Danimer Scientific, Inc.
DNMR
| $32.8K | ﹤0.01% |
1,357
+823
| +154% | +$25.6K |
|
4627
Verrica Pharmaceuticals
VRCA
$92.8M
| $32.7K | ﹤0.01% |
449
+68
| +18% | +$5.22K |
|
|
CVAC
4628
DELISTED
CureVac
CVAC
| $32.7K | ﹤0.01% |
9,615
+3,791
| +65% | +$12.4K |
|
4629
Virco
VIRC
$94.7M
| $32.6K | ﹤0.01% |
2,339
+2,335
| +58,375% | +$29K |
|
4630
Bank7 Corp
BSVN
$478M
| $32.6K | ﹤0.01% |
1,041
+333
| +47% | +$9.62K |
|
4631
Aveanna Healthcare
AVAH
$2.15B
| $32.4K | ﹤0.01% |
11,753
+2,267
| +24% | +$5.65K |
|
4632
Fidelity MSCI Utilities Index ETF
FUTY
$2.37B
| $32.4K | ﹤0.01% |
738
+97
| +15% | +$4.3K |
|
4633
Global Water Resources
GWRS
$215M
| $32.4K | ﹤0.01% |
2,679
+666
| +33% | +$8.31K |
|
4634
First Western Financial
MYFW
$308M
| $32.4K | ﹤0.01% |
1,904
+356
| +23% | +$5.84K |
|
4635
Jakks Pacific
JAKK
$305M
| $32.4K | ﹤0.01% |
1,807
+417
| +30% | +$8.23K |
|
4636
Global X S&P 500 Covered Call ETF
XYLD
$3.21B
| $32.3K | ﹤0.01% |
800
| – | – |
|
4637
Medallion Financial
MFIN
$229M
| $32.3K | ﹤0.01% |
4,204
-95,508
| -96% | -$756K |
|
4638
Foghorn Therapeutics
FHTX
$301M
| $32.2K | ﹤0.01% |
5,601
+2,216
| +65% | +$13.2K |
|
4639
Flexsteel Industries
FLXS
$317M
| $32.2K | ﹤0.01% |
1,036
-10,981
| -91% | -$393K |
|
|
ADVM
4640
DELISTED
Adverum Biotechnologies
ADVM
| $32K | ﹤0.01% |
4,669
-47,936
| -91% | -$446K |
|
4641
Investar Holding Corp
ISTR
$415M
| $32K | ﹤0.01% |
2,076
-18,525
| -90% | -$293K |
|
4642
Bel Fuse Inc Class A
BELFA
$2.99B
| $31.6K | ﹤0.01% |
+391
| New | +$29.5K |
|
4643
VanEck Agribusiness ETF
MOO
$998M
| $31.6K | ﹤0.01% |
450
-37,416
| -99% | -$2.71M |
|
|
BGFV
4644
DELISTED
Big 5 Sporting Goods
BGFV
| $31.5K | ﹤0.01% |
10,658
+6,426
| +152% | +$21.2K |
|
4645
Telomir Pharmaceuticals
TELO
$81.2M
| $31.5K | ﹤0.01% |
6,554
-11,194
| -63% | -$69.8K |
|
4646
Escalade
ESCA
$275M
| $31.5K | ﹤0.01% |
2,281
+167
| +8% | +$2.24K |
|
4647
First Trust Exchange-Traded Fund VI Multi-Asset Diversified Income Index Fund
MDIV
$432M
| $31.4K | ﹤0.01% |
2,000
| – | – |
|
4648
USCB Financial Holdings
USCB
$414M
| $31.4K | ﹤0.01% |
2,450
+357
| +17% | +$4.16K |
|
4649
Contango Silver & Gold Inc
CTGO
$529M
| $31.4K | ﹤0.01% |
1,738
+363
| +26% | +$7.39K |
|
|
GBIO
4650
DELISTED
Generation Bio
GBIO
| $31.4K | ﹤0.01% |
1,113
+262
| +31% | +$8.51K |
|
Similar funds
Citigroup's Q2 2024 Portfolio in Review
As of Q2 2024, Citigroup held 5,888 positions worth $156B, up 2.5% from $152B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citigroup's Q2 2024 filing shows 274 new, 2,819 increased, 1,798 reduced and 330 closed positions. Its largest new stake was Ferrovial N.V. Ordinary Shares: 8,935,948 shares worth $344M. The largest sale was iShares MSCI EAFE ETF, an estimated $313M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Citigroup's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 8,935,948 shares worth $344M.
- Citigroup added most to Intel in Q2 2024, an estimated $436M increase.
- Citigroup's biggest Q2 2024 reduction was iShares MSCI EAFE ETF, cutting an estimated $313M.
- Citigroup fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $79.7M.
- Citigroup's ten largest holdings make up 22% of its $156B portfolio in Q2 2024.
- Citigroup opened 274 new positions and closed 330 in Q2 2024.
- Citigroup's portfolio value rose 2.5% quarter-over-quarter to $156B.
Based on Citigroup's 13F filing for Q2 2024, filed 12 Aug 2024.